304 related articles for article (PubMed ID: 22519268)
1. [IgM enriched immunoglobulins as a therapy for sepsis and autoimmune diseases].
Yehudai D; Vadasz Z
Harefuah; 2012 Mar; 151(3):171-4, 188. PubMed ID: 22519268
[TBL] [Abstract][Full Text] [Related]
2. Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis.
Norrby-Teglund A; Haque KN; Hammarström L
J Intern Med; 2006 Dec; 260(6):509-16. PubMed ID: 17116001
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
[TBL] [Abstract][Full Text] [Related]
5. Role of pentoxifylline and/or IgM-enriched intravenous immunoglobulin in the management of neonatal sepsis.
Akdag A; Dilmen U; Haque K; Dilli D; Erdeve O; Goekmen T
Am J Perinatol; 2014 Nov; 31(10):905-12. PubMed ID: 24515621
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
Sapir T; Blank M; Shoenfeld Y
Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
[TBL] [Abstract][Full Text] [Related]
7. The use of IgM-enriched immunoglobulin in adult patients with sepsis.
Kakoullis L; Pantzaris ND; Platanaki C; Lagadinou M; Papachristodoulou E; Velissaris D
J Crit Care; 2018 Oct; 47():30-35. PubMed ID: 29886064
[TBL] [Abstract][Full Text] [Related]
8. [Mechanisms of action of intravenous immunoglobulins in the treatment of autoimmune diseases].
Mouthon L; Hurez V; Kazatchkine M
Ann Med Interne (Paris); 1993; 144(8):506-13. PubMed ID: 8179238
[TBL] [Abstract][Full Text] [Related]
9. Use of Intravenous Immunoglobulins in Sepsis Therapy-A Clinical View.
Jarczak D; Kluge S; Nierhaus A
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32756325
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin therapy for autoimmune diseases.
Arnson Y; Shoenfeld Y; Amital H
Autoimmunity; 2009 Sep; 42(6):553-60. PubMed ID: 19657774
[TBL] [Abstract][Full Text] [Related]
11. Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases.
Mouthon L; Kaveri S; Kazatchkine M
Transfus Sci; 1994 Dec; 15(4):393-408. PubMed ID: 10155557
[TBL] [Abstract][Full Text] [Related]
12. To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock.
Neugebauer EA
Crit Care Med; 2007 Dec; 35(12):2855-6. PubMed ID: 18043203
[No Abstract] [Full Text] [Related]
13. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
[TBL] [Abstract][Full Text] [Related]
14. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.
Ballow M
J Allergy Clin Immunol; 2011 Feb; 127(2):315-23; quiz 324-5. PubMed ID: 21185071
[TBL] [Abstract][Full Text] [Related]
15. Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases.
Hurez V; Kaveri SV; Kazatchkine MD
J Autoimmun; 1993 Dec; 6(6):675-81. PubMed ID: 8155249
[TBL] [Abstract][Full Text] [Related]
16. High dose intravenous immunoglobulin treatment: mechanisms of action.
Boros P; Gondolesi G; Bromberg JS
Liver Transpl; 2005 Dec; 11(12):1469-80. PubMed ID: 16315304
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.
Bayry J; Thirion M; Misra N; Thorenoor N; Delignat S; Lacroix-Desmazes S; Bellon B; Kaveri S; Kazatchkine MD
Neurol Sci; 2003 Oct; 24 Suppl 4():S217-21. PubMed ID: 14598046
[TBL] [Abstract][Full Text] [Related]
18. Impact of Immunoglobulin Therapy in Pediatric Disease: a Review of Immune Mechanisms.
Wong PH; White KM
Clin Rev Allergy Immunol; 2016 Dec; 51(3):303-314. PubMed ID: 26142065
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulins in neonatal sepsis: has the final word been said?
Capasso L; Borrelli AC; Ferrara T; Coppola C; Cerullo J; Izzo F; Caiazza R; Lama S; Raimondi F
Early Hum Dev; 2014 Sep; 90 Suppl 2():S47-9. PubMed ID: 25220128
[TBL] [Abstract][Full Text] [Related]
20. The patient: Emerging clinical applications of intravenous immunoglobulin.
Harvey RD
Pharmacotherapy; 2005 Nov; 25(11 Pt 2):85S-93S. PubMed ID: 16229679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
